Oral Presentation details
Title:Novel Oral Rapid-Acting Neuroactive Steroid for Treatment of Postpartum Depression: A Placebo-Controlled Phase 3 Clinical Trial of LPCN 1154
Presenter:Benjamin Bruno, PhD, Vice President, Clinical Development, Lipocine
Session:Pharmaceutical Pipeline (Oral Presentation)
Date:Tuesday, May 26, 2026
Time:3:20 PM ET
Location:Loews Miami Beach Hotel, Miami, FL

The presentation will highlight results from Lipocine's Phase 3 placebo-controlled trial evaluating LPCN 1154 (oral brexanolone) for the treatment of postpartum depression (PPD).

Poster Presentation
Date:Wednesday, May 27, 2026
Time:11:45 AM – 1:30 PM ET
Session:Poster Session 1, Pharmaceutical Pipeline
Poster number:W98